Cargando…
Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
BACKGROUND: Immunomodulators and biologics are cornerstones in the management of inflammatory bowel disease [IBD], but are associated with increased risk of infections. Post-marketing surveillance registries are pivotal to assess this risk, yet mainly focus on severe infections. Data on the prevalen...
Autores principales: | Rezazadeh Ardabili, Ashkan, van Esser, Dirk, Wintjens, Dion, Cilissen, Mia, Deben, Debbie, Mujagic, Zlatan, Russ, Fritzi, Stassen, Laurents, Van Bodegraven, Adriaan A, Wong, Dennis, Winkens, Bjorn, Jonkers, Daisy, Romberg-Camps, Mariëlle, Pierik, Marie J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320484/ https://www.ncbi.nlm.nih.gov/pubmed/36795060 http://dx.doi.org/10.1093/ecco-jcc/jjad023 |
Ejemplares similares
-
Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022) -
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2021) -
Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
por: Creemers, Rob H., et al.
Publicado: (2021) -
Disease Activity Patterns of Crohn’s Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort
por: Wintjens, Dion, et al.
Publicado: (2020) -
Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)